Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Avtozma 162 mg/0.9 ml Solution for injection pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
tocilizumab
Company:  
Celltrion Healthcare UK Limited See contact details
ATC code: 
L04AC07
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Avtozma Dosing guide

{healthcare_pro_orange} For Healthcare Professionals

Avtozma dosing guide - includes preparation and administration guides

{pdf_link}

Avtozma HCP brochure

{healthcare_pro_orange} For Healthcare Professionals

HCP brochure

{pdf_link}

Avtozma Patient Alert card

Patient alert card

{pdf_link}

Avtozma Patient Brochure

Patient brochure

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Celltrion Healthcare UK Limited
Company image
Address
Celltrion Healthcare UK Limited, The Charter Building, Charter Place, Uxbridge, UB8 1JG, UK
WWW
http://www.celltrionhealthcare.co.uk/
Telephone
01753 983 500
Medical Information Direct Line
01753 983 500
Medical Information e-mail
[email protected]
Customer Care direct line
01753 983 500
Adverse event reporting email
[email protected]